HLS Therapeutics Investor Presentation — May 2022

Document content

Tim Hendrickson | CFO

Q1 2022 Results Conference Call

May 5, 2022TSX -HLSForward -looking statements

Certain statements in this presentation are “forward -looking statements”. Any statements that express or involve

discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events

or performance (often, but not always using words or phrases such as “project”, “forecast”, “target”, “expect”, “seek”,

“endeavour ”, “anticipate”, “plan”, “estimate”, “believe”, “intend”, or stating that certain actions, events or results may,

could, should, would, might or will occur or be taken, or achieved) are not statements of historical fact and may be

“forward -looking statements”. Forward -looking statements are based on expectations, estimates and projections at the

time the statements are made that involve a number of known and unknown risks and uncertainties which would cause

actual results or events to differ materially from those presently anticipated. A number of factors could cause actual

results, performance or achievements to be materially different from any future results, performance or achievements that

may be expressed or implied by such forward -looking statements. Should one or more of these risks or uncertainties

materialize, or should assumptions underlying the forward -looking statements prove incorrect, actual results, performance

or achievements could vary materially from those expressed or implied by the forward -looking statements contained in

this presentation. These factors should be considered carefully and prospective investors should not place undue reliance

on these forward -looking statements. Although the forward -looking statements contained in this presentation are based

upon what HLS currently believes to be reasonable assumptions, HLS cannot assure prospective investors that actual

results, performance or achievements will be consistent with these forward -looking statements. Except as required by law,

HLS does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any

forward -looking statement, nor does it intend, or assume any obligation, to update or revise these forward -looking

statements to reflect new events or circumstances.

* All figures in USD unless otherwise noted.

2 HLS THERAPEUTICS INC.Provided May 5, 2022, as part of an oral presentation and qualified by such, contains forward -looking statements, actual results may vary materially; HLS disclaims any duty to updateTSX -HLSVascepa : strong rebound in physician interaction in March